Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparum

BACKGROUND: Long regarded as an epicenter of drug-resistant malaria, Southeast Asia continues to provide new challenges to the control of Plasmodium falciparum malaria. Recently, resistance to the artemisinin combination therapy partner drug piperaquine has been observed in multiple locations across...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Malar J
Autors principals: Ansbro, Megan R., Jacob, Christopher G., Amato, Roberto, Kekre, Mihir, Amaratunga, Chanaki, Sreng, Sokunthea, Suon, Seila, Miotto, Olivo, Fairhurst, Rick M., Wellems, Thomas E., Kwiatkowski, Dominic P.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Methodology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7218657/
https://ncbi.nlm.nih.gov/pubmed/32404110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-020-03249-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars